Laurianne Rochelle-La
Tours, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Response kinetics following CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry.
Journal: Bone marrow transplantation
Published: March 09, 2026
Outcomes and salvage strategies for large B-cell lymphoma progressing after second-line CAR T-cell therapy: A DESCAR-T study from the LYSA group.
Journal: HemaSphere
Published: December 05, 2025
Large B-cell lymphoma: The LYSA pragmatic guidelines.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 21, 2025
Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma treated with anti-CD19 CAR-T cells: CARTHYM, a study from the French national DESCAR-T registry.
Journal: HemaSphere
Published: November 28, 2024
Outcome of patients with large B-cell lymphoma treated with tafasitamab plus lenalidomide either before or after CAR T-cell therapy.
Journal: Blood advances
Published: May 28, 2024
A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma.
Journal: Nature medicine
Published: March 29, 2022
Medium-term follow-up of patients treated with chimeric antigen receptor T cells (CAR T cells): Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Journal: Bulletin du cancer
Published: October 02, 2020
First-line treatment of double-hit and triple-hit lymphomas: Survival and tolerance data from a retrospective multicenter French study.
Journal: American journal of hematology
Published: September 13, 2020
Last Updated: 09/26/2026